Inhibition of MEIS1–HOXB13 activity by the aminoglycosides neomycin and paromomycin facilitates cardiomyocyte proliferation and heart regeneration.
References
Haubner, B. J. et al. Circ. Res. 118, 216–221 (2016).
Yuan, X. & Braun, T. Curr. Opin. Genet. Dev. 82, 102098 (2023).
Garbern, J. C. & Lee, R. T. Dev. Cell 57, 424–439 (2022).
Aharonov, A. et al. Nat. Cell Biol. 22, 1346–1356 (2020).
Leach, J. P. et al. Nature 550, 260–264 (2017).
Mahmoud, A. I. et al. Nature 497, 249–253 (2013).
Nguyen, N. U. N. et al. Nature 582, 271–276 (2020).
Li, X. et al. Nature 622, 619–626 (2023).
Chen, Y. et al. Science 373, 1537–1540 (2021).
Ahmed, M. S. et al. Nat. Cardiovasc. Res. https://doi.org/10.1038/s44161-024-00450-y (2924).
Zeitz, M. J. & Smyth, J. W. J. Cardiovasc. Dev. Dis. 7, 9 (2020).
Tang, T. W. H. et al. Circulation 139, 647–659 (2019).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Rights and permissions
About this article
Cite this article
Yuan, X., Braun, T. Toward drug-induced heart regeneration. Nat Cardiovasc Res 3, 260–261 (2024). https://doi.org/10.1038/s44161-024-00446-8
Published:
Issue Date:
DOI: https://doi.org/10.1038/s44161-024-00446-8
- Springer Nature Limited